AI and Climate Change
12:00 p.m. - 1:30 p.m.
Penn Kleinman Center for Energy Policy, 220 S. 34th St.
A group of five scientists received the Transformative Research Award for a project focusing on cancer research, while three investigators received the New Innovator Award for independent projects developed by early-career investigators.
The award from Japan’s oldest private university honors outstanding contributions to medicine and life sciences.
The findings, from a team led by Golnaz Vahedi of Penn Medicine, could have implications for T-cell based immunotherapies for cancer and other conditions.
Proceeds from the July auction of the non-fungible token—a digital asset—will benefit ongoing research at Penn.
The generosity of Penn alumnus Michael Armellino creates a center for the care of patients with the rare genetic condition across all stages of life and propels scientific discovery.
A Penn study finds beta-hydroxybutyrate, an alternative-energy molecule produced by the body in response to starvation or low-carb diets, strongly suppresses the growth of colorectal tumors.
A Penn Medicine study used wearable tech to foster activity in high-risk, diverse populations, specifically postpartum women to reduce their cardiovascular risk.
PHMC Health Center on Cedar, staffed by Penn Medicine clinicians, offers comprehensive primary and behavioral health care for residents in the West and Southwest Philadelphia community.
The new center, funded by the National Institute of Environmental Health Sciences, aims to identify and protect children in vulnerable communities from environmental exposures.
An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack heart fibroblast cells via only a single injection of mRNA.